Company intelligence
Cellbricks Therapeutics
Offering a scalable solution to restore lost tissue and organ function for millions of patients.
About Cellbricks Therapeutics
Cellbricks Therapeutics is a Berlin-based biotech company pioneering the future of regenerative medicine and longevity. Built on deeptech innovation, the company combines proprietary 3D- bioprinting technology with advanced biomaterials and human cells to develop implantable tissue grafts for clinical use. Cellbricks’ mission is to transform healthcare by restoring organ function and replacing damaged tissue with living, functional implants – produced reliably and at scale. For inquiries please contact: Moritz Marschall mm@cellbricks.com
Verified activity
Signals from Cellbricks Therapeutics
5 published signals
Presence & Recognition
Cellbricks Therapeutics is represented by Marta Maciel and Zeynab Mirzaei at the 35th Annual Conference of the European Society for Biomaterials (ESB 2026) in Antwerp, Belgium.
Reported by Cellbricks Therapeutics
People
Cellbricks Therapeutics is hiring a Head of Finance and Investor Relations role based in Berlin to bring finance operations in-house.
Reported by Alexander Leutner
People
Cellbricks Therapeutics is hiring a Head of Finance and CFO in Berlin to scale the balance sheet.
Reported by Lutz Kloke
People
Cellbricks Therapeutics is currently hiring for a Head of Finance, a Laboratory Technician, and a Tissue Engineer - Histology & Imaging Specialist.
Reported by Cellbricks Therapeutics
People
Cellbricks Therapeutics hired Enrico Accastelli, PhD, Yannis Lazis, Ph.D., and Maria Simoglou as part of the growing team.
Reported by Cellbricks Therapeutics